Antihypertensive Efficacy of Fixed Combination Azilsartan Medoxomil / Chlorthalidone in Patients With Uncontrolled Arterial Hypertension

AIM: To study effects of a fixed azilsartan medoxomil/chlorthalidone combination (Edarbi Clo) on clinical, ambulatory and central blood pressure (BP) in patients with uncontrolled arterial hypertension (AH)). MATERIALS AND METHODS: Patients (n=25) with uncontrolled AH were given fixed azilsartan medoxomil/chlorthalidone combination (40 / 12.5 mg / day) for 4 weeks. After 4 weeks, in patients who did not achieve target BP levels the dose was increased up to 40 / 25 mg / day. Duration of the study was 12 weeks. RESULTS: After 12 weeks of treatment 88 % of patients achieved target clinical BP (.

Авторы
Редакторы
-
Журнал
Издательство
KlinMed Consulting
Номер выпуска
11
Язык
Русский
Страницы
12-18
Статус
Опубликовано
Подразделение
-
DOI
-
Номер
-
Том
57
Год
2017
Организации
  • 1 Federal State Autonomous Educational Institution of Higher Education, "Peoples' Friendship University of Russia"
Ключевые слова
azilsartan medoxomil, chlorthalidone, ambulatory blood pressure monitoring, efficacy, safety
Дата создания
19.07.2019
Дата изменения
19.07.2019
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/39098/